Table 1.

Study measures.

Measure				Aim		Cronbach α		ωa		Time of assessment
Diagnostic interview
	MINIb		Psychiatric diagnosis		N/Ac		N/A		BLd
Primary outcomes
	BDI-IIe		Severity of depression		.91		0.91		BL, Post-Tf
	BAIg		Severity of anxiety		.92		0.92		BL, Post-T
	PANASh		Positive and negative affect		PAi=.91; NAj=.89		PA=0.91; NA=0.89		BL, Post-T
Secondary outcomes
	Personality measures
		NEO FFIk	Neuroticism and extraversion		Nl=.81; Em=.84		N=0.82; E=0.84		BL, Post-T
	Quality of life
		EQ-5Dn	Health-related quality of life		.67		0.70		BL, Post-T
	Expectation and opinion
		Expectation of treatment scale	Expectation of treatment		N/A		N/A		BL
		Opinion of treatment scale	Opinion of treatment		N/A		N/A		Post-T

^aω: coefficient omega in this study.

^bMINI: Mini-International Neuropsychiatric Interview, Version 5.0.0.

^cN/A: not applicable.

^dBL: baseline.

^eBDI-II: Beck Depression Inventory-II.

^fPost-T: posttreatment.

^gBAI: Beck Anxiety Inventory.

^hPANAS: Positive and Negative Affect Schedule.

ⁱPA: positive affect.

^jNA: negative affect.

^kNEO FFI: NEO Five Factor Inventory.

^lN: neuroticism.

^mE: extraversion.

ⁿEQ-5D: EuroQoL-5D Questionnaire.